H7R expression is regulated as a late viral gene, with synthesis dependent on DNA replication. Research methodologies to study its temporal expression include:
Experimental approach:
Infect cells (e.g., BS-C-1 cells) with recombinant virus expressing tagged H7
Harvest at various time points post-infection (e.g., 6h, 9h, 12h, 24h)
Analyze protein synthesis by SDS-PAGE and Western blotting
Include cytosine arabinoside (AraC) treatment to block DNA replication
Use antibodies against both H7 and known late proteins (e.g., A3) as controls
Key findings:
H7 protein (17 kDa) shows a late time course of synthesis and accumulation
Expression is first detected at approximately 9 hours post-infection
No H7 is detected even at 24 hours when DNA replication is blocked with AraC
The promoter sequence contains TAAATG, indicative of a late promoter
This experimental design allows researchers to definitively characterize the temporal expression pattern of H7R and confirm its classification as a late protein.
Several expression systems have been developed for producing recombinant H7R protein:
For successful purification of recombinant H7R, researchers should consider:
Lysis conditions (ionic vs. non-ionic detergents)
Affinity chromatography selection based on tag
Buffer optimization for stability and solubility
Quality control by functional assays (e.g., phospholipid binding)
H7R has been identified as a phosphoinositide-binding protein that specifically interacts with phosphatidylinositol-3-phosphate (PI3P) and phosphatidylinositol-4-phosphate (PI4P) . To study this function, researchers can employ:
Methodological workflow:
Site-directed mutagenesis:
Target positively charged residues in the basic surface patch
Prepare alanine substitution mutants of key residues
Express and purify mutant proteins using affinity chromatography
Lipid binding assays:
Protein-lipid overlay assays using PIP strips
Liposome co-sedimentation assays
Surface plasmon resonance to determine binding kinetics
Isothermal titration calorimetry for thermodynamic parameters
Functional assays:
Transfect mutant constructs into cells infected with H7-deficient virus
Measure viral titer rescue and plaque formation
Analyze membrane structure formation by electron microscopy
Correlation of lipid binding with functional rescue
Key research findings:
Studies of the vaccinia H7 homolog demonstrated that mutation of positively charged residues in the phosphoinositide binding site disrupted both lipid binding and viral replication, establishing a direct link between these functions .
Since H7R is essential for virus replication, conditional expression systems are necessary for functional studies. A methodology for creating and using such systems includes:
Experimental design:
Creation of inducible H7R expression system:
Replace the endogenous H7R gene with one regulated by a bacteriophage T7 promoter and E. coli lac operator
Include a parent virus containing both E. coli lac repressor and phage T7 RNA polymerase
Engineer repressor to be expressed constitutively under tandem early and late promoters
Make T7 polymerase inducible via a lac operator regulating a late promoter
Two-step virus construction:
First, insert H7 gene with epitope tag adjacent to T7 promoter and lac operator
Second, replace endogenous H7R gene with a marker (e.g., GFP)
Conduct homologous recombination in the presence of IPTG inducer
Clonally purify the resultant virus with inducible H7R expression
Functional analysis:
Conduct plaque formation assays ±IPTG
Perform one-step growth experiments at varying IPTG concentrations
Monitor H7 expression by Western blotting
Carry out complementation experiments with plasmids expressing wild-type H7
Validation findings:
The inducible H7 mutant produces plaques only when IPTG is present
Optimal virus yield occurs at ≥100 μM IPTG
In the absence of inducer, only single infected cells are observed
Complementation with plasmid-expressed H7 under its natural promoter increases infectious virus yield by ~10-fold
Repression of H7R expression leads to specific ultrastructural changes that can be studied using various microscopy techniques:
Methodological approach:
Confocal microscopy setup:
Infect cells with inducible H7R virus ±IPTG
Fix at various timepoints (6, 9, 12, 24 hours post-infection)
Use DAPI to stain DNA/viral factories
Employ antibodies against H7 and viral membrane/core proteins
Use fluorescent secondary antibodies for visualization
Transmission electron microscopy:
Prepare thin sections of infected cells
Use immunogold labeling for specific proteins
Examine membrane structures and viral factories
Advanced techniques to consider:
Correlative light and electron microscopy (CLEM)
Cryo-electron tomography for 3D ultrastructure
Super-resolution microscopy for detailed protein localization
Live-cell imaging with fluorescently tagged proteins
Key observations when H7 is repressed:
Large spherical inclusions containing viral core proteins appear within cytoplasmic factories
Inclusions are very dense, with antibodies binding only to surfaces (appearing as rings in Z-sections)
Crescent membranes and immature virions (IVs) are not formed
Some dense inclusions have membrane segments partially coated with spicules (D13 trimers)
Most D13 scaffold protein is present in separate intermediate-density inclusions associated with ER membranes
H7R functions as part of a group of viral membrane assembly proteins (VMAPs) that collectively contribute to viral membrane biogenesis. These include A11, L2, A6, and A30.5 . To study these interactions:
Experimental approaches:
Protein-protein interaction studies:
Co-immunoprecipitation with epitope-tagged proteins
Proximity labeling approaches (BioID, APEX)
Yeast two-hybrid or mammalian two-hybrid screening
Split-GFP complementation assays
FRET/BRET to study interactions in living cells
Functional interaction studies:
Comparative analysis of conditional mutants for each VMAP
Complementation tests between different VMAP mutants
Synchronized induction/repression of multiple VMAPs
Analysis of membrane formation by electron microscopy
Structural approaches:
X-ray crystallography of VMAP complexes
Cryo-EM of multiprotein assemblies
Hydrogen-deuterium exchange mass spectrometry
Cross-linking mass spectrometry
Research findings on H7R and other VMAPs:
Current evidence indicates that H7 and A11 (another VMAP) function at similar steps in morphogenesis, despite having no sequence homology. Both proteins:
Are expressed late in infection and not incorporated into mature virions
When repressed, inhibit processing of A17 membrane protein and core proteins
Prevent formation of crescent membranes and immature virions
Lead to formation of electron-dense inclusions containing core proteins
Result in intermediate-density inclusions containing D13 and ER membranes
Some recombinant viral proteins, including hemagglutinin (HA) from influenza viruses, can form oligomeric structures called subviral particles (SVPs) that enhance immunogenicity. Similar approaches may be applicable to H7R:
Methodological workflow:
Production and purification of oligomeric H7R:
Express full-length H7R with transmembrane domain
Use mild detergent extraction
Perform size exclusion chromatography
Analyze oligomeric state by cross-linking experiments
Characterization of SVPs:
Negative stain electron microscopy to visualize particles
Dynamic light scattering for size distribution
Analytical ultracentrifugation for molecular weight determination
Circular dichroism for secondary structure analysis
Functional assessment:
Hemagglutination activity (if applicable)
Lipid binding assays
Stability assessment at various temperatures
Immunogenicity testing in animal models
Comparative findings from influenza research:
Studies with recombinant influenza H7 hemagglutinin show that the full-length protein forms oligomeric pleomorphic SVPs of ~20 nm diameter composed of approximately 10 HA0 molecules . These SVPs demonstrate:
Retained functional ability to agglutinate red blood cells
No significant quantities of free monomeric protein
These findings suggest that the formation of SVPs may be a general property of viral membrane proteins that could potentially be exploited for H7R studies and vaccine development.
Scientific literature searches can be supplemented with analysis of Google's "People Also Ask" (PAA) data to identify emerging research questions:
Methodological approach:
Data collection:
Perform searches for relevant terms ("Variola virus H7R protein," "poxvirus membrane formation," etc.)
Record PAA questions that appear
Click on questions to expand the PAA box and reveal additional related questions
Compile questions into a database
Analysis techniques:
Categorize questions by research domain
Identify knowledge gaps based on unanswered or partially answered questions
Track changes in questions over time to identify trending topics
Compare PAA results across different geographic regions
Application to research planning:
Use identified questions to develop research hypotheses
Address gaps in current knowledge with new experimental approaches
Structure research papers to directly answer common questions
Format findings to optimize visibility in PAA results
Key insights for researchers:
PAA questions appear in over 80% of English searches, generally within the first few results
Questions cascade down when clicked, revealing additional related queries
Content that directly answers questions in the first paragraph is more likely to be featured
Using question wording as title tags and H1 headings increases chances of selection for PAA results
This approach provides researchers with insights into what information other scientists and the public are seeking about H7R protein, potentially guiding more impactful research directions.
Studying authentic variola H7R function presents significant challenges due to biosafety restrictions:
Methodological workarounds:
Recombinant protein approaches:
Chimeric virus strategies:
Create vaccinia viruses expressing variola H7R
Develop complementation systems in H7-deficient vaccinia
Analyze function in appropriate cellular contexts
Compare with wild-type vaccinia controls
Computational approaches:
Molecular dynamics simulations of protein structure and interactions
Sequence-based evolutionary analysis across poxvirus species
Protein-protein interaction prediction
Virtual screening for potential inhibitors
Limitations to consider:
Authentic post-translational modifications may be missing in recombinant systems
Protein-protein interactions specific to variola may not be recapitulated
The cellular environment of human-specific infection cannot be fully modeled
Historical variola strains may have shown H7R sequence diversity not captured in available databases
Ensuring the functionality of recombinant H7R protein requires rigorous quality control:
Quality control workflow:
Physical characterization:
SDS-PAGE for purity and expected molecular weight (17 kDa for untagged H7R)
Western blotting with specific antibodies
Mass spectrometry for precise mass determination and detection of modifications
Circular dichroism for secondary structure verification
Functional assays:
Phosphoinositide binding tests (PIP strips, liposome binding)
Oligomerization assessment by size exclusion chromatography
Thermal shift assays for stability determination
Electron microscopy for structural integrity
Biological activity tests:
Complementation of H7-deficient vaccinia virus
Cell-based membrane formation assays
Co-immunoprecipitation with known binding partners
Immunofluorescence for proper subcellular localization
Data-based quality benchmarks:
A properly folded, functional H7R protein should:
Form oligomeric structures rather than remain monomeric
Bind specifically to PI3P and PI4P phosphoinositides
Complement growth of H7-deficient vaccinia when expressed in trans
These quality control steps ensure that experimental observations truly reflect H7R function rather than artifacts of improperly produced protein.